Concepedia

Simon Wöhrle

SW

16

Publications

2.1K

Citations

16

H-Index

2006

Active since

Affiliations

Boehringer Ingelheim (Austria)(Current)

University of Freiburg

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Boehringer Ingelheim (Germany)

Simon Wöhrle is an author at Boehringer Ingelheim (Austria) specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

2006–2022

16

Publications

16

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design

William Farnaby, Manfred Koegl, Michael J. Roy et al. · Nature Chemical Biology · 2019 · 553 citations · Full text

, , +10

FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor

Vito Guagnano, Audrey Kauffmann, Simon Wöhrle et al. · Cancer Discovery · 2012 · 352 citations · Full text

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo

Christiane Kofink, Nicole Trainor, Barbara Mair et al. · Nature Communications · 2022 · 194 citations · Full text

Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets

Simon Wöhrle, Christine Henninger, Olivier Bonny et al. · Journal of Bone and Mineral Research · 2012 · 146 citations · Full text

, , +19

FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone

Simon Wöhrle, Olivier Bonny, Noémie Beluch et al. · Journal of Bone and Mineral Research · 2011 · 145 citations

Rows per page

1–5 of 16